Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice.
about
Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDLCholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosisMacrophage functions in atherosclerosisCholesterol, inflammation and innate immunityReactive Oxygen Species (ROS) Mediate p300-dependent STAT1 Protein Interaction with Peroxisome Proliferator-activated Receptor (PPAR)-γ in CD36 Protein Expression and Foam Cell FormationLiver X Receptors Link Lipid Metabolism and Inflammation.LDL cholesterol modulates human CD34+ HSPCs through effects on proliferation and the IL-17 G-CSF axisAllicin induces the upregulation of ABCA1 expression via PPARγ/LXRα signaling in THP-1 macrophage-derived foam cellsDisruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.Mechanisms that regulate macrophage burden in atherosclerosis.Placental ABCA1 Expression Is Increased in Spontaneous Preterm Deliveries Compared with Iatrogenic Preterm Deliveries and Term Deliveries.Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.IL-24 gene polymorphisms are associated with cardiometabolic parameters and cardiovascular risk factors but not with premature coronary artery disease: the genetics of atherosclerotic disease Mexican study.microRNAs and HDL life cycle.Regulation and consequences of monocytosisATP-binding cassette transporter 1 attenuates ovalbumin-induced neutrophilic airway inflammation.Recent developments in vascular biologyHigh-density lipoprotein: a novel target for antirestenosis therapyABCA1 and nascent HDL biogenesisThe mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosisFoam cells and the pathogenesis of kidney disease.LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling.MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout MiceFunctional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease.Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.The rs7044343 Polymorphism of the Interleukin 33 Gene Is Associated with Decreased Risk of Developing Premature Coronary Artery Disease and Central Obesity, and Could Be Involved in Regulating the Production of IL-33.ABCA1 agonist peptides for the treatment of disease.Macrophage Phenotype and Function in Different Stages of Atherosclerosis.Association between Polymorphisms and Haplotype in the ABCA1 Gene and Overweight/Obesity Patients in the Uyghur Population of China.Disordered haematopoiesis and athero-thrombosis.Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice.CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice.Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.Subverting sterols: rerouting an oxysterol-signaling pathway to promote tumor growthSystemic and renal lipids in kidney disease development and progression.Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport.Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype.Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.Sphingomyelin depletion impairs anionic phospholipid inward translocation and induces cholesterol efflux.Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis
P2860
Q26801507-0B5EA359-44ED-466A-9009-35028DEF429BQ26861206-808D48B2-847A-448F-A982-5E9EDA428005Q26864369-28BA70C5-6E36-4ADA-A28E-90F62C1F3A7CQ28086912-82C73AC7-926D-4C86-92F3-18481D32FA5DQ28115789-910F0A06-A1DC-45DD-BFBD-B626F35996A1Q30252316-ED05F26D-36C0-4572-BB0C-696D2BF6CB08Q31133829-540BDFD6-E16F-4246-8B85-E52504D1C3F5Q33675106-BB05537E-6720-40D8-9EAB-2E1AE17BA1D4Q33757132-46F9A4F6-5329-4FE9-9135-0FF56F51BA91Q33761114-5642A70D-8B61-4DBF-A5F7-543AACF89F3AQ33786716-8539CC3D-9DC7-4B81-96E6-895D0BB54C46Q34076117-E91F62F8-14FC-4FEB-9B94-CADDD30F260EQ34113876-849E86E1-AC09-41C7-9DDE-11812346E681Q34248289-00266EEF-D65D-4C94-9136-83A9D79F2E9EQ34372534-59A33148-5A6B-4E78-BBFF-9C66D8A695B3Q34471217-70D1B44D-00DF-4016-8772-C842F0E20C96Q34662445-BF2CFF5C-F56C-4225-AE0C-BD73B0823B3DQ34714464-40A56FB8-B5A1-4042-8CDD-587F8ADD1EEAQ34958342-3CF76243-0949-49E8-BF32-3B8FFDC3E0D0Q35104236-4FDAE973-BAFE-400C-8176-9919C4B20A88Q35738502-D5F2D2C7-D832-4843-9F1B-973AD1AA566FQ35896184-446C03B8-F2A8-4F28-BD59-2AE7DD9A5948Q36039213-13D9BB72-A1FD-4583-A5F7-5B1921CAF11CQ36047289-3779422E-C16E-4430-8975-E7E1A200D5C1Q36201821-8B4E6137-560A-451A-A9FF-37BDCBA6715BQ36237960-F9202CD5-CBD3-4C44-BEBE-62143BCD1F26Q36436785-49AC1256-AFFE-4229-B4DE-E36AA3FE9F51Q36602809-E8A94DEB-0595-424C-A075-36ED9F2D90EBQ36633926-D6658523-A89E-4FBA-9927-0DFF960FD172Q36773876-78A4A9C5-AF73-41C4-A93B-851D4B6A843EQ36849582-14134261-BEA3-4E0E-BAA5-3FEE41C9EA0FQ37032384-91E2CAB0-6133-4555-8435-518E83A3A628Q37033745-E96AE8FC-4628-4485-80BF-2CF0CDC56617Q37125772-04D3E2C4-3CCB-4A56-8AF1-8C93199135D6Q37148885-7195A3CD-1BEB-4128-B1E1-EF4BCC9D0C2CQ37236276-A61E8087-A964-4E60-BC64-693D5F579BFDQ37297571-445D18B3-D1D6-4FC5-807A-58783F8B3063Q37358482-30751A01-D7A5-4ECB-BA17-A1199F5A8A38Q37415663-A7FC1A05-21F7-4B9B-906F-26E8765490E6Q37542828-7C309E64-1808-4B46-A0AB-3F964A9F4A9D
P2860
Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Deficiency of ATP-binding cass ...... rates atherosclerosis in mice.
@en
Deficiency of ATP-binding cass ...... rates atherosclerosis in mice.
@nl
type
label
Deficiency of ATP-binding cass ...... rates atherosclerosis in mice.
@en
Deficiency of ATP-binding cass ...... rates atherosclerosis in mice.
@nl
prefLabel
Deficiency of ATP-binding cass ...... rates atherosclerosis in mice.
@en
Deficiency of ATP-binding cass ...... rates atherosclerosis in mice.
@nl
P2093
P2860
P50
P1433
P1476
Deficiency of ATP-binding cass ...... erates atherosclerosis in mice
@en
P2093
Alan R Tall
Carrie Welch
Darren J Gorman
John S Parks
Marit Westerterp
Mojdeh S Kappus
Sandra Abramowicz
Tamara A Pagler
P2860
P304
P356
10.1161/CIRCRESAHA.113.301086
P577
2013-04-09T00:00:00Z